Genesco Statistics
Total Valuation
Genesco has a market cap or net worth of $210.50 million. The enterprise value is $661.58 million.
Important Dates
The next estimated earnings date is Friday, May 30, 2025, before market open.
| Earnings Date | May 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Genesco has 11.04 million shares outstanding. The number of shares has decreased by -3.62% in one year.
| Current Share Class | 11.04M |
| Shares Outstanding | 11.04M |
| Shares Change (YoY) | -3.62% |
| Shares Change (QoQ) | +2.27% |
| Owned by Insiders (%) | 9.18% |
| Owned by Institutions (%) | 91.93% |
| Float | 8.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 12.50 |
| PS Ratio | 0.09 |
| Forward PS | 0.09 |
| PB Ratio | 0.39 |
| P/TBV Ratio | 0.41 |
| P/FCF Ratio | 4.50 |
| P/OCF Ratio | 2.40 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 9.56, with an EV/FCF ratio of 14.15.
| EV / Earnings | n/a |
| EV / Sales | 0.28 |
| EV / EBITDA | 9.56 |
| EV / EBIT | 39.48 |
| EV / FCF | 14.15 |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.89.
| Current Ratio | 1.60 |
| Quick Ratio | 0.22 |
| Debt / Equity | 0.89 |
| Debt / EBITDA | 1.32 |
| Debt / FCF | 10.38 |
| Interest Coverage | 3.39 |
Financial Efficiency
Return on equity (ROE) is -3.49% and return on invested capital (ROIC) is 0.99%.
| Return on Equity (ROE) | -3.49% |
| Return on Assets (ROA) | 0.79% |
| Return on Invested Capital (ROIC) | 0.99% |
| Return on Capital Employed (ROCE) | 1.75% |
| Revenue Per Employee | $129,170 |
| Profits Per Employee | -$1,049 |
| Employee Count | 18,000 |
| Asset Turnover | 1.74 |
| Inventory Turnover | 3.05 |
Taxes
In the past 12 months, Genesco has paid $28.82 million in taxes.
| Income Tax | 28.82M |
| Effective Tax Rate | 309.63% |
Stock Price Statistics
The stock price has decreased by -24.40% in the last 52 weeks. The beta is 2.26, so Genesco's price volatility has been higher than the market average.
| Beta (5Y) | 2.26 |
| 52-Week Price Change | -24.40% |
| 50-Day Moving Average | 27.51 |
| 200-Day Moving Average | 30.96 |
| Relative Strength Index (RSI) | 39.89 |
| Average Volume (20 Days) | 464,205 |
Short Selling Information
The latest short interest is 971,303, so 8.80% of the outstanding shares have been sold short.
| Short Interest | 971,303 |
| Short Previous Month | 622,728 |
| Short % of Shares Out | 8.80% |
| Short % of Float | 10.88% |
| Short Ratio (days to cover) | 2.19 |
Income Statement
In the last 12 months, Genesco had revenue of $2.33 billion and -$18.89 million in losses. Loss per share was -$1.74.
| Revenue | 2.33B |
| Gross Profit | 1.10B |
| Operating Income | 16.76M |
| Pretax Income | -23.40M |
| Net Income | -18.89M |
| EBITDA | 69.22M |
| EBIT | 16.76M |
| Loss Per Share | -$1.74 |
Full Income StatementBalance Sheet
The company has $34.01 million in cash and $485.09 million in debt, giving a net cash position of -$451.08 million or -$40.87 per share.
| Cash & Cash Equivalents | 34.01M |
| Total Debt | 485.09M |
| Net Cash | -451.08M |
| Net Cash Per Share | -$40.87 |
| Equity (Book Value) | 546.97M |
| Book Value Per Share | 48.40 |
| Working Capital | 228.97M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $87.89 million and capital expenditures -$41.13 million, giving a free cash flow of $46.75 million.
| Operating Cash Flow | 87.89M |
| Capital Expenditures | -41.13M |
| Free Cash Flow | 46.75M |
| FCF Per Share | $4.24 |
Full Cash Flow StatementMargins
Gross margin is 47.17%, with operating and profit margins of 0.72% and -0.81%.
| Gross Margin | 47.17% |
| Operating Margin | 0.72% |
| Pretax Margin | 0.40% |
| Profit Margin | -0.81% |
| EBITDA Margin | 2.98% |
| EBIT Margin | 0.72% |
| FCF Margin | 2.01% |